Repligen (RGEN) Tops Q2 EPS by 15c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Repligen Corp (NASDAQ: RGEN) | Delayed: 178.71 -1.3 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $180.01 | 52 Week High | $33.79 | |||
| Open | $179.45 | 52 Week Low | $20.07 | |||
| Day High | $185.03 | P/E | 255.30 | |||
| Day Low | $175.96 | EPS | $0.70 | |||
| Volume | 1,272,417 | |||||
